Total Valuation
Veri Medtech Holdings has a market cap or net worth of $40.00M. The enterprise value is $35.97M.
Market Cap$40.00M
Enterprise Value$35.97M
Share Statistics
Veri Medtech Holdings has 8,000,004 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,000,004
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Veri Medtech Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count25
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Veri Medtech Holdings is ―. Veri Medtech Holdings’s PEG ratio is 0.00.
PE Ratio―
PS Ratio2.30
PB Ratio-10.59
Price to Fair Value―
Price to FCF79.06
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Veri Medtech Holdings had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Veri Medtech Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.10
52-Week Price Change84.16%
50-Day Moving Average5.29
200-Day Moving Average3.76
Relative Strength Index (RSI)31.24
Average Volume (3m)15.00
Important Dates
Veri Medtech Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Veri Medtech Holdings as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Veri Medtech Holdings has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Veri Medtech Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Veri Medtech Holdings has ― in cash and marketable securities with $422.14K in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt$422.14K
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Veri Medtech Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast46.53%
EPS Growth Forecast-237.01%